{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:13:01Z","timestamp":1789701181226,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":822,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1038\/jid.2013.85","type":"journal-article","created":{"date-parts":[[2013,2,25]],"date-time":"2013-02-25T14:48:33Z","timestamp":1361803713000},"page":"2212-2220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Targeted Delivery of Tumor Necrosis Factor\u2013Related Apoptosis-Inducing Ligand to Keratinocytes with a Pemphigus mAb"],"prefix":"10.1016","volume":"133","author":[{"given":"Michiyoshi","family":"Kouno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman M.","family":"Schechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Seykora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2013.85_bb0010","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1517\/14728222.2010.519701","article-title":"TRAIL receptor signaling and therapeutics","volume":"14","author":"Abdulghani","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"10.1038\/jid.2013.85_bb0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2013.85_bb0020","doi-asserted-by":"crossref","first-page":"22522","DOI":"10.1074\/jbc.M010505200","article-title":"The cytokines tumor necrosis factor-alpha (TNF-alpha) and TNF-related apoptosis-inducing ligand differentially modulate proliferation and apoptotic pathways in human keratinocytes expressing the human papillomavirus-16 E7 oncoprotein","volume":"276","author":"Basile","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2013.85_bb0025","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/sj.cdd.4402213","article-title":"Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L","volume":"14","author":"Berg","year":"2007","journal-title":"Cell Death Differ"},{"key":"10.1038\/jid.2013.85_bb0030","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1593\/neo.04229","article-title":"Exceptionally potent anti-tumor bystander activity of an scFv:sTRAIL fusion protein with specificity for EGP2 toward target antigen-negative tumor cells","volume":"6","author":"Bremer","year":"2004","journal-title":"Neoplasia"},{"key":"10.1038\/jid.2013.85_bb0035","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1158\/0008-5472.CAN-04-2756","article-title":"Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7","volume":"65","author":"Bremer","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2013.85_bb0040","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.onc.1209802","article-title":"DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis","volume":"26","author":"Chen","year":"2007","journal-title":"Oncogene"},{"key":"10.1038\/jid.2013.85_bb0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/1476-4598-9-301","article-title":"Melanoma-associated chondroitin sulfate proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo","volume":"9","author":"de Bruyn","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1038\/jid.2013.85_bb0050","doi-asserted-by":"crossref","first-page":"e12178","DOI":"10.1371\/journal.pone.0012178","article-title":"Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact","volume":"5","author":"Elrod","year":"2010","journal-title":"PLoS One"},{"key":"10.1038\/jid.2013.85_bb0055","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.4049\/jimmunol.174.4.1888","article-title":"Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand","volume":"174","author":"Hirata","year":"2005","journal-title":"J Immunol"},{"key":"10.1038\/jid.2013.85_bb0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/lary.20151","article-title":"Desmoglein 3 is overexpressed in inverted papilloma and squamous cell carcinoma of sinonasal cavity","volume":"120","author":"Huang","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1038\/jid.2013.85_bb0065","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.jid.5701132","article-title":"Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies","volume":"128","author":"Ishii","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.85_bb0070","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1046\/j.1523-1747.2003.12636.x","article-title":"Tumor necrosis factor related apoptosis inducing ligand triggers apoptosis in dividing but not in differentiating human epidermal keratinocytes","volume":"121","author":"Jansen","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.85_bb0075","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.4049\/jimmunol.1102437","article-title":"TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-alpha-mediated antitumor reactivity","volume":"188","author":"Kalb","year":"2012","journal-title":"J Immunol"},{"key":"10.1038\/jid.2013.85_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1476-4598-10-34","article-title":"Targeted expression of tumor necrosis factor-related apoptosis-inducing ligand TRAIL in skin protects mice against chemical carcinogenesis","volume":"10","author":"Kedinger","year":"2011","journal-title":"Mol Cancer"},{"key":"10.1038\/jid.2013.85_bb0085","doi-asserted-by":"crossref","first-page":"29247","DOI":"10.1074\/jbc.273.44.29247","article-title":"Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand","volume":"273","author":"Kothny-Wilkes","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2013.85_bb0090","first-page":"553","article-title":"Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes","volume":"60","author":"Leverkus","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2013.85_bb0095","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.4049\/jimmunol.168.10.4881","article-title":"Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells","volume":"168","author":"Lunemann","year":"2002","journal-title":"J Immunol"},{"key":"10.1038\/jid.2013.85_bb0100","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/art.27501","article-title":"Liposome-bound APO2L\/TRAIL is an effective treatment in a rabbit model of rheumatoid arthritis","volume":"62","author":"Martinez-Lostao","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1038\/jid.2013.85_bb0105","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jmb.2004.09.079","article-title":"Foldon, the natural trimerization domain of T4 fibritin, dissociates into a monomeric A-state form containing a stable beta-hairpin: atomic details of trimer dissociation and local beta-hairpin stability from residual dipolar couplings","volume":"344","author":"Meier","year":"2004","journal-title":"J Mol Biol"},{"key":"10.1038\/jid.2013.85_bb0110","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ni1328","article-title":"See no evil, hear no evil, do no evil: the lessons of immune privilege","volume":"7","author":"Niederkorn","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1038\/jid.2013.85_bb0115","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1172\/JCI24185","article-title":"Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display","volume":"115","author":"Payne","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2013.85_bb0120","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.4049\/jimmunol.162.10.6053","article-title":"TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege","volume":"162","author":"Phillips","year":"1999","journal-title":"J Immunol"},{"key":"10.1038\/jid.2013.85_bb0125","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/86401","article-title":"Avoiding premature apoptosis of normal epidermal cells","volume":"7","author":"Qin","year":"2001","journal-title":"Nat Med"},{"key":"10.1038\/jid.2013.85_bb0130","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1038\/cddis.2010.45","article-title":"Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins","volume":"1","author":"Schneider","year":"2010","journal-title":"Cell Death Dis"},{"key":"10.1038\/jid.2013.85_bb0135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.bjc.6605470","article-title":"Pemphigus vulgaris antigen mRNA quantification for the staging of sentinel lymph nodes in head and neck cancer","volume":"102","author":"Solassol","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1038\/jid.2013.85_bb0140","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.4049\/jimmunol.161.5.2195","article-title":"TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells","volume":"161","author":"Thomas","year":"1998","journal-title":"J Immunol"},{"issue":"Pt 2","key":"10.1038\/jid.2013.85_bb0145","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1042\/bj3500505","article-title":"Functional analysis of tumour necrosis factor-alpha-related apoptosis-inducing ligand (TRAIL): cysteine-230 plays a critical role in the homotrimerization and biological activity of this novel tumoricidal cytokine","volume":"350","author":"Trabzuni","year":"2000","journal-title":"Biochem J"},{"key":"10.1038\/jid.2013.85_bb0150","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1210\/en.2008-1389","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells","volume":"150","author":"Wang","year":"2009","journal-title":"Endocrinology"},{"key":"10.1038\/jid.2013.85_bb0155","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/hed.21598","article-title":"Clinical significance of TRAIL and TRAIL receptors in patients with head and neck cancer","volume":"33","author":"Yoldas","year":"2011","journal-title":"Head Neck"},{"key":"10.1038\/jid.2013.85_bb0160","first-page":"2747","article-title":"Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma","volume":"59","author":"Zhang","year":"1999","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2013.85_bb0165","doi-asserted-by":"crossref","first-page":"9439","DOI":"10.1158\/0008-5472.CAN-09-2976","article-title":"Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53","volume":"69","author":"Zhao","year":"2009","journal-title":"Cancer Res"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15364034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15364034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T21:00:18Z","timestamp":1743973218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15364034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0022202X15364034"],"URL":"https:\/\/doi.org\/10.1038\/jid.2013.85","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted Delivery of Tumor Necrosis Factor\u2013Related Apoptosis-Inducing Ligand to Keratinocytes with a Pemphigus mAb","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2013.85","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}